Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) saw a significant drop in short interest in December. As of December 30th, there was short interest totalling 10,200 shares, a drop of 23.9% from the December 15th total of 13,400 shares. Based on an average trading volume of 23,600 shares, the days-to-cover ratio is currently 0.4 days.
Core One Labs Trading Down 7.3 %
OTCMKTS:CLABF traded down $0.04 during trading hours on Thursday, reaching $0.52. The company had a trading volume of 270 shares, compared to its average volume of 7,381. Core One Labs has a 1-year low of $0.22 and a 1-year high of $1.49. The business's 50 day moving average price is $0.61 and its 200-day moving average price is $0.49.
Get
Core One Labs alerts:
About Core One Labs
(Get Rating)
Core One Labs Inc operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents.
See Also
- Get a free copy of the StockNews.com research report on Core One Labs (CLABF)
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
- Microsoft Layoffs Signal Layoffs for Other Tech Companies?
- More Than One Reason To Buy Fastenal, Quickly
Receive News & Ratings for Core One Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core One Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Core One Labs Inc.(场外交易代码:CLABF-GET Rating)12月份空头股数销量大幅下降。截至12月30日,空头股数共有10,200股,比12月15日的13,400股减少了23.9%。以平均成交量23,600股计算,目前天数与回补比率为0.4天。
Core One Labs降价7.3%
OTCMKTS:CLABF周四交易时段下跌0.04美元,至0.52美元。该公司的成交量为270股,而其平均成交量为7381股。Core One Labs的一年低点为0.22美元,一年高位为1.49美元。该业务的50日移动均线价格为0.61美元,其200日移动均线价格为0.49美元。
到达
核心一号实验室警报:
关于Core One实验室
(获取评级)
Core One Labs Inc.是一家生物技术研究和技术生命科学公司。该公司专注于通过新型给药系统、迷幻辅助心理治疗和原料药级别裸盖菇素制造将迷幻药物推向市场。其CannaStrips技术生产的注射条允许大麻成分的生物利用度。
另请参阅
- 免费获取StockNews.com关于Core One实验室(CLABF)的研究报告
- 高股息率的必和必拓认为中国推动了23年的增长
- 爱彼迎的涨幅是否会像分析师预测的那样达到38%?
- 特斯拉汽车降价是否意味着特斯拉股票也会降价?
- 微软的裁员标志着其他科技公司的裁员?
- 快速购买Fastenal的原因不止一个
每日接收Core One实验室的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对Core One Labs及相关公司评级的每日简要摘要。